The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/28502
StudyName: Eligibility Breast Cancer NCT02513472
Date of export from the portal: 02.07.2020
Copyright Holder: https://clinicaltrials.gov/show/NCT02513472
Date of Upload / last change: 20.01.2018
License: Creative Commons BY 4.0

----

Description: 
Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Combination With Pembrolizumab in Subjects With Metastatic Triple-Negative Breast Cancer (mTNBC); ODM derived from: https://clinicaltrials.gov/show/NCT02513472
